EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Research progress on drugs targeting mitochondria‑associated membranes for the treatment of atherosclerosis (Review)

Shaoying An, Wenhui Sun, Lizhou Shi, Hai Chen, Zhongcheng Mo

Molecular Medicine Reports · 2026

DOI: 10.3892/mmr.2026.13987 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecular Medicine Reports, 2026. Verfasst von Shaoying An und 4 weiteren Autor:innen. Beteiligte Einrichtung: Guangxi Key Laboratory of Diabetic Systems Medicine, Department of Histology and Embryology, Guilin Medical University, Guilin, Guangxi Zhuang Autono…. Hauptthemen laut MEDLINE: Atherosclerosis, Mitochondria Associated Membranes, Mitochondria. Die Arbeit nennt 115 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mitochondria‑associated membranes (MAMs) are specialized contact sites between the endoplasmic reticulum and mitochondria, and serve as the structural foundation for material exchange and signal transduction between these two organelles. MAMs serve critical roles in lipid metabolism, calcium homeostasis, mitochondrial dynamics, autophagy and inflammatory regulation, all of which are closely involved in the pathogenesis of atherosclerosis (AS). Dysregulation of MAM function can promote oxidative stress and chronic inflammation, thereby accelerating atherosclerotic progression. The present review focuses on the molecular mechanisms through which MAMs regulate key cellular processes and influence AS development. Advances in therapeutic agents that target MAMs are summarized, including metformin, statins, 4‑phenylbutyric acid and traditional Chinese medicine compounds, which exert anti‑atherosclerotic effects by restoring MAM integrity, modulating calcium signalling and inhibiting inflammasome activation. By integrating the current knowledge on MAM biology and pharmacology, the present review aims to provide novel strategies for the prevention and treatment of AS through targeted regulation of MAMs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AtherosclerosisMitochondria Associated MembranesMitochondriaHumansAnimalsLipid MetabolismOxidative StressCalciumAutophagy

Stichwörter der Autor:innen

atherosclerosisautophagycalcium homeostasislipid metabolismmitochondria‑associated membranes

Substanzen

Calcium

Autor:innen und Institutionen

  • Guangxi Key Laboratory of Diabetic Systems Medicine, Department of Histology and Embryology, Guilin Medical University, Guilin, Guangxi Zhuang Autonomous Region 541199, P.R. China.
  • Department of Medical Science Experiment Centre, Guilin Medical University Affiliated Lingshan Hospital, The People's Hospital of Lingshan County, Qinzhou, Guangxi Zhuang Autonomous Region 535499, P.R. China.

Zitieren

APA

An, S., Sun, W., Shi, L., Chen, H., & Mo, Z. (2026). Research progress on drugs targeting mitochondria‑associated membranes for the treatment of atherosclerosis (Review). Molecular Medicine Reports. https://doi.org/10.3892/mmr.2026.13987

Vancouver

An S, Sun W, Shi L, Chen H, Mo Z. Research progress on drugs targeting mitochondria‑associated membranes for the treatment of atherosclerosis (Review). Molecular Medicine Reports. 2026. doi:10.3892/mmr.2026.13987

BibTeX
@article{An2026,
  author = {An, Shaoying and Sun, Wenhui and Shi, Lizhou and Chen, Hai and Mo, Zhongcheng},
  title = {Research progress on drugs targeting mitochondria‑associated membranes for the treatment of atherosclerosis (Review)},
  journal = {Molecular Medicine Reports},
  year = {2026},
  doi = {10.3892/mmr.2026.13987}
}
Kostenlos starten →